These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21800013)

  • 41. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS
    Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
    Schinner E; Salb K; Schlossmann J
    Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agrin-induced AChR aggregate formation requires cGMP and aggregate maturation requires activation of cGMP-dependent protein kinase.
    Jones MA; Werle MJ
    Mol Cell Neurosci; 2004 Feb; 25(2):195-204. PubMed ID: 15019937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP; Cheng CY
    Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A VASP-Rac-soluble guanylyl cyclase pathway controls cGMP production in adipocytes.
    Jennissen K; Siegel F; Liebig-Gonglach M; Hermann MR; Kipschull S; van Dooren S; Kunz WS; Fässler R; Pfeifer A
    Sci Signal; 2012 Aug; 5(239):ra62. PubMed ID: 22932701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
    Kobsar A; Koessler J; Kehrer L; Gambaryan S; Walter U
    Thromb Haemost; 2012 Mar; 107(3):521-9. PubMed ID: 22234363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclic guanosine monophosphate dependent pathway contributes to human mast cell inhibitory actions of the nitric oxide donor, diethylamine NONOate.
    Yip KH; Huang Y; Leung FP; Lau HY
    Eur J Pharmacol; 2010 Apr; 632(1-3):86-92. PubMed ID: 20096283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
    Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
    Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
    Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
    Pyriochou A; Vassilakopoulos T; Zhou Z; Papapetropoulos A
    Life Sci; 2007 Nov; 81(21-22):1549-54. PubMed ID: 17945311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preserved fertility despite erectile dysfunction in mice lacking the nitric oxide receptor.
    Groneberg D; Lies B; König P; Jäger R; Friebe A
    J Physiol; 2013 Jan; 591(2):491-502. PubMed ID: 23129789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme.
    Mullershausen F; Russwurm M; Thompson WJ; Liu L; Koesling D; Friebe A
    J Cell Biol; 2001 Oct; 155(2):271-8. PubMed ID: 11604422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats.
    Masaki E; Kondo I
    Anesth Analg; 1999 Aug; 89(2):484-9. PubMed ID: 10439772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
    De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
    Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An ex vivo standardized assay to measure human platelet cGMP.
    di Villa Bianca Rd; Mitidieri E; Mirone V; Fusco F; Imbimbo C; Cirino G; Sorrentino R
    J Pharmacol Toxicol Methods; 2011; 64(2):164-7. PubMed ID: 21801844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of nitric oxide/cGMP system in platelet function].
    Inoue N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():500-4. PubMed ID: 15506436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.